PRKG is activated by binding to high levels of cGMP in the absence of WNT signaling

Stable Identifier
R-HSA-4551453
Type
Reaction [binding]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Active PKG homodimers restrict Ca2+ release in the absence of stimulation by phosphorylating a component of the IP3 receptor complex. PKG homodimers are activated at high (sub- to micromolar) concentrations of cGMP. Upon binding of cGMP to the high and low affinity sites in the regulatory domain, an allosteric change in secondary structure makes the catalytic site accessible to substrate (reviewed in Hoffman, 2005). WNT5A signaling through FZD2 in mouse F9 teratocarcinoma cells results in a PDE6-dependent decrease in cGMP levels. Under low cGMP conditions, the N-terminal domain of PKG occludes the catalytic site, reducing PKG activity and promoting Ca2+ release through the IP3 receptor (Ahumada et al, 2002; Ma and Yang, 2006).

Literature References
PubMed ID Title Journal Year
12471263 Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP

Ahumada, A, Slusarski, DC, Liu, X, Moon, RT, Malbon, CC, Wang, HY

Science 2002
15545263 The biology of cyclic GMP-dependent protein kinases

Hofmann, F

J Biol Chem 2005
16920709 Suppression of cyclic GMP-dependent protein kinase is essential to the Wnt/cGMP/Ca2+ pathway

Ma, L, Wang, HY

J. Biol. Chem. 2006
Participants
Participant Of
hasEvent
Inferred From
Authored
Reviewed
Created